8-K Announcements
6Material company update
Apr 28, 2026·SEC
Material company update
Mar 24, 2026·SEC
Material company update
Mar 10, 2026·SEC
Centene Corporation(CNC)Earnings, Financials & Key Ratios
CNC•NYSE•Insurance & Managed Care
Price updated Jun 19, 2026
AboutCentene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray, home-based primary care, transportation assistance, vision care, dental care, telehealth, immunization, specialty pharmacy, therapy, social work, nurse advisory, and care coordination services, as well as prescriptions and limited over-the-counter drugs, medical equipment, and behavioral health and abuse services. This segment also offers various individual, small group, and large group commercial healthcare products to employers and directly to members. The company's Specialty Services segment provides pharmacy benefits management services; nurse advice line and after-hours support services; vision and dental services, as well as staffing services to correctional systems and other government agencies; and services to Military Health System eligible beneficiaries. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.Show more
- Revenue$194.78B+19.4%
- Combined Ratio103.91%+6.0%
- Net Income-$6.67B-301.9%
- Return on Equity-28.66%-327.5%
- Medical Cost Ratio87.76%-2.1%
- Operating Margin-3.91%-300.9%
- Net Margin-3.43%-269.0%
- ROA-8.34%-310.7%
- Equity / Assets25.83%-19.7%
CNC Key Insights
Centene Corporation (CNC) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Momentum leader: RS Rating 92 (top 8%)
- ✓Share count reduced 6.2% through buybacks
- ✓Trading at only 1.5x book value
✗Weaknesses
- ✗High loss ratio of 87.8%
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when CNC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
CNC Price & Volume
Centene Corporation (CNC) stock price & volume — 10-year historical chart
Loading chart...
CNC Growth Metrics
Centene Corporation (CNC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years23.95%
5 Years11.88%
3 Years10.45%
TTM17.02%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-286.59%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-295.83%
Return on Capital
10 Years5.58%
5 Years0.86%
3 Years-0.64%
Last Year-14.6%
CNC Recent Earnings
Centene Corporation (CNC) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 12/12 qtrs (100%)
Q2 2026Latest
Apr 28, 2026Metric
Actual
Est
EPS
$3.37+51.1%
$2.23
Rev
$49.9B+5.1%
$47.5B
Q1 2026
Feb 6, 2026Metric
Actual
Est
EPS
$1.19+2.5%
$1.22
Rev
$49.7B+2.7%
$48.4B
Q4 2025
Oct 29, 2025Metric
Actual
Est
EPS
$0.50+445.4%
$0.14
Rev
$49.7B+4.1%
$47.7B
Q3 2025
Jul 25, 2025Metric
Actual
Est
EPS
$0.16-243.4%
$0.11
Rev
$48.7B+10.4%
$44.1B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 28, 2026 | $3.37vs $2.23+51.1% | $49.9Bvs $47.5B+5.1% |
| Q1 2026 | Feb 6, 2026 | $1.19vs $1.22+2.5% | $49.7Bvs $48.4B+2.7% |
| Q4 2025 | Oct 29, 2025 | $0.50vs $0.14+445.4% | $49.7Bvs $47.7B+4.1% |
| Q3 2025 | Jul 25, 2025 | $0.16vs $0.11-243.4% | $48.7Bvs $44.1B+10.4% |
Based on last 12 quarters of dataView full earnings history →
CNC Peer Comparison
Centene Corporation (CNC) competitors in Government Program Managed Care — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 MOH | 10.18B | 195.37 | 21.90 | 11.75% | 0.42% | 4.44% | 0.97 | |
 UNH | 363.94B | 400.96 | 30.31 | 11.81% | 2.68% | 11.54% | 0.77 | |
 ELV | 84.37B | 388.50 | 15.47 | 12.62% | 2.62% | 11.92% | 0.75 | |
 HUM | 43.3B | 360.65 | 36.65 | 10.06% | 0.82% | 6.17% | 0.73 | |
 CVS | 125.45B | 98.32 | 70.73 | 7.85% | 0.72% | 3.86% | 1.24 | |
 ALHC | 4.47B | 21.86 | -5908.11 | 46.06% | 0.47% | 11.5% | 1.89 | |
 OSCR | 7.36B | 28.40 | -16.80 | 27.5% | -0.3% | -3.26% | 0.44 | |
 CLOV | 2.59B | 5.00 | -29.41 | 40.34% | -2.58% | -17.08% |
Compare CNC vs Peers
Centene Corporation (CNC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CNC Income Statement
Centene Corporation (CNC) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 48.38B | 60.12B | 74.64B | 111.11B | 125.98B | 144.55B | 154B | 163.07B | 194.78B | 198.1B |
Revenue Growth % | 19.15% | 24.25% | 24.16% | 48.87% | 13.38% | 14.74% | 6.54% | 5.89% | 19.44% | 17.02% |
Medical Costs & Claims | 42.58B | 51.7B | 65.8B | 95.9B | 111.78B | 127.89B | 136.68B | 146.24B | 170.94B | 168.53B |
Medical Cost Ratio % | 88.01% | 85.99% | 88.15% | 86.31% | 88.73% | 88.48% | 88.76% | 89.68% | 87.76% | 85.07% |
Gross Profit | 5.8B▲ 0% | 8.42B▲ 45.2% | 8.84B▲ 5.0% | 15.22B▲ 72.1% | 14.2B▼ 6.7% | 16.66B▲ 17.3% | 17.32B▲ 4.0% | 16.83B▼ 2.8% | 23.83B▲ 41.6% | 29.57B▲ 0% |
Gross Margin % | 11.99% | 14.01% | 11.85% | 13.69% | 11.27% | 11.52% | 11.24% | 10.32% | 12.24% | 14.93% |
Gross Profit Growth % | 4.64% | 45.16% | 5.01% | 72.07% | -6.68% | 17.3% | 3.96% | -2.81% | 41.62% | - |
Operating Expenses | 4.6B | 6.96B | 7.06B | 12.13B | 12.41B | 15.34B | 14.38B | 13.65B | 31.45B | 36.86B |
OpEx / Revenue % | 9.51% | 11.58% | 9.46% | 10.92% | 9.85% | 10.61% | 9.34% | 8.37% | 16.15% | 18.61% |
Depreciation & Amortization | 361M | 495M | 643M | 1.26B | 1.33B | 1.43B | 1.29B | 1.24B | 1.27B | 960M |
Combined Ratio % | 97.52% | 97.57% | 97.61% | 97.23% | 98.58% | 99.09% | 98.1% | 98.05% | 103.91% | 103.68% |
Operating Income | 1.2B▲ 0% | 1.46B▲ 21.6% | 1.78B▲ 22.2% | 3.08B▲ 73.0% | 1.78B▼ 42.1% | 1.32B▼ 26.1% | 2.93B▲ 122.3% | 3.17B▲ 8.4% | -7.62B▼ 339.9% | -7.29B▲ 0% |
Operating Margin % | 2.48% | 2.43% | 2.39% | 2.77% | 1.42% | 0.91% | 1.9% | 1.95% | -3.91% | -3.68% |
Operating Income Growth % | -5.07% | 21.6% | 22.15% | 73.05% | -42.12% | -26.12% | 122.31% | 8.36% | -339.95% | - |
EBITDA | 1.56B | 1.95B | 2.42B | 4.34B | 3.12B | 2.75B | 4.22B | 4.42B | -6.34B | -5.93B |
EBITDA Margin % | 3.22% | 3.25% | 3.25% | 3.91% | 2.48% | 1.9% | 2.74% | 2.71% | -3.26% | -2.99% |
Interest Expense | 255M | 343M | 412M | 728M | 665M | 665M | 725M | 702M | 678M | 672M |
Non-Operating Income | -190M | -253M | -413M | -419M | -694M | -1.31B | -1.39B | -1.78B | -1.2B | -1.22B |
Pretax Income | 1.13B▲ 0% | 1.37B▲ 20.6% | 1.78B▲ 30.3% | 2.77B▲ 55.6% | 1.81B▼ 34.6% | 1.96B▲ 8.2% | 3.6B▲ 83.4% | 4.26B▲ 18.3% | -6.73B▼ 258.0% | -6.37B▲ 0% |
Pretax Margin % | 2.34% | 2.28% | 2.39% | 2.5% | 1.44% | 1.36% | 2.34% | 2.61% | -3.45% | -3.22% |
Income Tax | 326M | 474M | 473M | 979M | 477M | 760M | 899M | 963M | -50.96M | 77.04M |
Effective Tax Rate % | 28.75% | 34.65% | 26.54% | 35.3% | 26.31% | 38.74% | 24.99% | 22.62% | 0.76% | -1.21% |
Net Income | 828M▲ 0% | 900M▲ 8.7% | 1.32B▲ 46.8% | 1.81B▲ 36.9% | 1.35B▼ 25.5% | 1.2B▼ 10.8% | 2.7B▲ 124.8% | 3.31B▲ 22.3% | -6.67B▼ 301.9% | -6.44B▲ 0% |
Net Margin % | 1.71% | 1.5% | 1.77% | 1.63% | 1.07% | 0.83% | 1.75% | 2.03% | -3.43% | -3.25% |
Net Income Growth % | 47.33% | 8.7% | 46.78% | 36.87% | -25.5% | -10.76% | 124.79% | 22.32% | -301.91% | -286.59% |
EPS (Diluted) | 2.35▲ 0% | 2.26▼ 3.8% | 3.14▲ 38.9% | 3.12▼ 0.6% | 2.28▼ 26.9% | 2.07▼ 9.2% | 4.95▲ 139.1% | 6.31▲ 27.5% | -13.62▼ 315.8% | -13.00▲ 0% |
EPS Growth % | 36.63% | -3.83% | 38.94% | -0.64% | -26.92% | -9.21% | 139.13% | 27.47% | -315.85% | -295.83% |
EPS (Basic) | 2.40 | 2.31 | 3.19 | 3.17 | 2.31 | 2.09 | 4.97 | 6.33 | -13.61 | - |
Diluted Shares Outstanding | 353.09M | 398.51M | 420.41M | 579.13M | 590.52M | 582.04M | 545.7M | 523.74M | 491.07M | 495.59M |
CNC Balance Sheet
Centene Corporation (CNC) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Assets | 21.86B | 30.9B | 40.99B | 68.72B | 78.38B | 76.87B | 84.64B | 82.44B | 77.66B | 81.17B |
Asset Growth % | 8.21% | 41.39% | 32.66% | 67.63% | 14.05% | -1.92% | 10.11% | -2.59% | -5.8% | -8.95% |
Total Investment Assets | 5.84B | 7.58B | 8.58B | 14.43B | 15.58B | 17B | 18.75B | 20.05B | 20.88B | 4M |
Long-Term Investments | 5.31B | 6.86B | 7.72B | 12.85B | 14.04B | 14.68B | 16.29B | 17.43B | 20.88B | 74.45B |
Short-Term Investments | 531M | 722M | 863M | 1.58B | 1.54B | 2.32B | 2.46B | 2.62B | 0 | 2.48B |
Total Current Assets | 8.7B | 12B | 20.32B | 23.39B | 28.5B | 30.13B | 40.76B | 38B | 35.99B | 44.99B |
Cash & Equivalents | 4.07B | 5.34B | 12.12B | 10.8B | 13.12B | 12.07B | 17.19B | 14.06B | 17.89B | 21.26B |
Receivables | 3.41B | 5.15B | 6.25B | 9.7B | 12.24B | 13.27B | 15.53B | 19.71B | 18.11B | 82.19B |
Other Current Assets | 687M | 784M | 1.09B | 1.32B | 1.6B | 2.46B | 5.57B | 1.6B | 0 | 1.82B |
Goodwill & Intangibles | 6.15B | 9.25B | 8.93B | 27.04B | 27.59B | 25.72B | 23.66B | 22.97B | 15.37B | 68.81B |
Goodwill | 4.75B | 7.01B | 6.86B | 18.65B | 19.77B | 18.81B | 17.56B | 17.56B | 10.84B | 10.84B |
Intangible Assets | 1.4B | 2.24B | 2.06B | 8.39B | 7.82B | 6.91B | 6.1B | 5.41B | 4.53B | 4.36B |
PP&E (Net) | 1.1B | 1.71B | 2.78B | 2.77B | 6.96B | 4.99B | 2.42B | 2.43B | 2.35B | 2.09B |
Other Assets | 589M | 1.08B | 1.25B | 2.66B | 1.28B | 1.35B | 1.52B | 1.62B | 2.16B | 2.3B |
Total Liabilities | 14.98B | 19.88B | 28.3B | 42.76B | 51.35B | 52.63B | 58.69B | 55.94B | 57.6B | 59.65B |
Total Debt | 4.7B | 6.69B | 14.51B | 18.32B | 22.66B | 21.33B | 18.88B | 19.43B | 18.78B | 16.37B |
Net Debt | 627M | 1.34B | 2.39B | 7.52B | 9.54B | 9.26B | 1.68B | 5.37B | 889M | -4.89B |
Long-Term Debt | 4.7B | 6.65B | 13.64B | 16.68B | 18.57B | 17.94B | 17.71B | 18.42B | 17.97B | 16.31B |
Short-Term Debt | 4M | 38M | 88M | 97M | 267M | 82M | 119M | 110M | 196M | 63M |
Total Current Liabilities | 9.33B | 11.97B | 12.93B | 21.59B | 25.77B | 28.46B | 36.72B | 34.26B | 21.48B | 40.05B |
Accounts Payable | 4.17B | 4.05B | 4B | 7.07B | 8.29B | 9.35B | 16.25B | 13.02B | 20.54B | 16.83B |
Deferred Revenue | 328M | 385M | 383M | 523M | 434M | 478M | 715M | 661M | 736M | 953M |
Other Current Liabilities | 4.29B | 6.83B | 7.47B | 12.23B | 14.24B | 16.75B | 18B | 18.31B | -50M | 5.37B |
Deferred Taxes | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 3.95B |
Other Liabilities | 952M | 1.26B | 921M | 1.62B | 1.99B | 2.48B | 2.74B | 1.83B | 15.8B | 2.55B |
Total Equity | 6.88B▲ 0% | 11.02B▲ 60.3% | 12.69B▲ 15.1% | 25.96B▲ 104.6% | 27.02B▲ 4.1% | 24.24B▼ 10.3% | 25.96B▲ 7.1% | 26.51B▲ 2.1% | 20.06B▼ 24.3% | 21.5B▲ 0% |
Equity Growth % | 13.58% | 60.31% | 15.14% | 104.55% | 4.08% | -10.31% | 7.09% | 2.13% | -24.35% | -70.62% |
Shareholders Equity | 6.85B | 10.92B | 12.55B | 25.77B | 26.8B | 24.06B | 25.84B | 26.41B | 19.95B | 21.43B |
Minority Interest | 26M | 106M | 141M | 189M | 227M | 180M | 116M | 100M | 103M | 75M |
Retained Earnings | 2.75B | 3.66B | 4.98B | 6.79B | 8.14B | 9.34B | 12.04B | 15.35B | 8.67B | 10.21B |
Common Stock | 4.35B | 0 | 0 | 1M | 1M | 1M | 1M | 1M | 1M | 1M |
Accumulated OCI | -3M | -56M | 134M | 337M | 77M | -1.13B | -652M | -504M | -58M | -171M |
Return on Equity (ROE) | 12.81% | 10.06% | 11.14% | 9.35% | 5.08% | 4.69% | 10.77% | 12.6% | -28.66% | -28.6% |
Return on Assets (ROA) | 3.94% | 3.41% | 3.67% | 3.3% | 1.83% | 1.55% | 3.35% | 3.96% | -8.34% | -7.87% |
Equity / Assets | 31.46% | 35.67% | 30.96% | 37.78% | 34.48% | 31.53% | 30.67% | 32.15% | 25.83% | 26.49% |
Debt / Equity | 0.68x | 0.61x | 1.14x | 0.71x | 0.84x | 0.88x | 0.73x | 0.73x | 0.94x | 0.76x |
Book Value per Share | 19.47 | 27.66 | 30.19 | 44.83 | 45.76 | 41.64 | 47.56 | 50.62 | 40.84 | 43.39 |
Tangible BV per Share | 2.06 | 4.44 | 8.96 | -1.86 | -0.97 | -2.55 | 4.21 | 6.76 | 9.55 | 12.72 |
CNC Cash Flow Statement
Centene Corporation (CNC) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 1.49B | 1.23B | 1.48B | 5.5B | 4.21B | 6.26B | 8.05B | 154M | 5.09B | 7.18B |
Operating CF Growth % | -19.56% | -17.13% | 20.18% | 271.07% | -23.59% | 48.89% | 28.62% | -98.09% | 3203.9% | 533.58% |
Operating CF / Revenue % | 3.08% | 2.05% | 1.99% | 4.95% | 3.34% | 4.33% | 5.23% | 0.09% | 2.61% | 3.62% |
Net Income | 808M | 894M | 1.31B | 1.79B | 1.34B | 1.2B | 2.7B | 3.29B | -6.68B | -6.44B |
Depreciation & Amortization | 361M | 495M | 643M | 1.26B | 1.48B | 1.55B | 1.29B | 1.24B | 1.27B | 932M |
Stock-Based Compensation | 135M | 145M | 177M | 281M | 203M | 234M | 216M | 212M | 204M | 154M |
Deferred Taxes | -108M | -129M | 55M | -51M | -132M | -631M | -78M | 13M | -60M | -13M |
Other Non-Cash Items | -1M | 1B | 301M | 25M | -54M | 1.71B | 546M | -91M | 9.52B | 9.93B |
Working Capital Changes | 294M | -171M | -1B | 2.19B | 1.38B | 2.19B | 3.37B | -4.51B | 823M | 2.63B |
Cash from Investing | -1.26B | -4.58B | -1.53B | -6.96B | -3.3B | -2.92B | -1.28B | -1.05B | 453M | 1.07B |
Capital Expenditures | -422M | -675M | -730M | -869M | -910M | -1B | -799M | -644M | -767M | -832M |
Acquisitions | -50M | -2.06B | -36M | -3.58B | -466M | 1.02B | 619M | 990M | -19M | -19M |
Purchase of Investments | -2.7B | -3.85B | -2.58B | -7.4B | -7.4B | -6.74B | -6.62B | -7.18B | -4.54B | -3.9B |
Sale/Maturity of Investments | 1.9B | 1.99B | 1.81B | 4.92B | 5.46B | 3.8B | 5.52B | 5.79B | 5.78B | 5.82B |
Other Investing | 12M | 0 | 0 | -22M | 19M | 0 | 0 | 0 | 0 | 0 |
Cash from Financing | -16M | 4.69B | 6.81B | 260M | 1.36B | -4.2B | -1.57B | -2.41B | -1.6B | -2.42B |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | -65M | -71M | -75M | -626M | -297M | -3.1B | -1.63B | -3.12B | -475M | -463M |
Stock Issued | 0 | 2.78B | 0 | 0 | 0 | 70M | 44M | 46M | 37M | 37M |
Debt Issuance (Net) | 1000K | 1000K | 1000K | 1000K | 1000K | -1000K | 1000K | 1000K | -1000K | -4M |
Other Financing | 5M | 9M | 16M | -34M | -102M | -41M | 0 | -6M | -19M | -6M |
Net Change in Cash | 142M▲ 0% | 1.27B▲ 794.4% | 6.78B▲ 433.9% | -1.32B▼ 119.5% | 2.32B▲ 275.2% | -1.04B▼ 145.0% | 5.12B▲ 590.3% | -3.13B▼ 161.1% | 3.83B▲ 222.2% | 5.7B▲ 0% |
Exchange Rate Effect | 0 | 9M | -2M | -131M | 50M | -187M | -85M | 174M | -114M | -131M |
Cash at Beginning | 3.93B | 4.07B | 5.34B | 12.12B | 10.8B | 13.12B | 12.07B | 17.19B | 14.16B | 17.96B |
Cash at End | 4.07B | 5.34B | 12.12B | 10.8B | 13.12B | 12.07B | 17.19B | 14.06B | 17.96B | 20.59B |
Free Cash Flow | 1.07B▲ 0% | 559M▼ 47.6% | 753M▲ 34.7% | 4.63B▲ 515.4% | 3.29B▼ 28.9% | 5.26B▲ 59.5% | 7.25B▲ 38.0% | -490M▼ 106.8% | 4.32B▲ 981.8% | 6.35B▲ 0% |
FCF Growth % | -30.94% | -47.61% | 34.7% | 515.4% | -28.9% | 59.54% | 37.99% | -106.75% | 981.84% | 325.34% |
FCF Margin % | 2.21% | 0.93% | 1.01% | 4.17% | 2.62% | 3.64% | 4.71% | -0.3% | 2.22% | 3.2% |
FCF per Share | 3.02 | 1.4 | 1.79 | 8 | 5.58 | 9.03 | 13.29 | -0.94 | 8.8 | 12.8 |
CNC Key Ratios
Centene Corporation (CNC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Combined Ratio | 97.52% | 97.57% | 97.61% | 97.23% | 98.58% | 99.09% | 98.1% | 98.05% | 103.91% | 103.68% |
Medical Cost Ratio | 88.01% | 85.99% | 88.15% | 86.31% | 88.73% | 88.48% | 88.76% | 89.68% | 87.76% | 85.07% |
Return on Equity (ROE) | 12.81% | 10.06% | 11.14% | 9.35% | 5.08% | 4.69% | 10.77% | 12.6% | -28.66% | -28.6% |
Return on Assets (ROA) | 3.94% | 3.41% | 3.67% | 3.3% | 1.83% | 1.55% | 3.35% | 3.96% | -8.34% | -7.87% |
Equity / Assets | 31.46% | 35.67% | 30.96% | 37.78% | 34.48% | 31.53% | 30.67% | 32.15% | 25.83% | 26.49% |
Book Value / Share | 19.47 | 27.66 | 30.19 | 44.83 | 45.76 | 41.64 | 47.56 | 50.62 | 40.84 | 43.39 |
Debt / Equity | 0.68x | 0.61x | 1.14x | 0.71x | 0.84x | 0.88x | 0.73x | 0.73x | 0.94x | 0.76x |
Revenue Growth | 19.15% | 24.25% | 24.16% | 48.87% | 13.38% | 14.74% | 6.54% | 5.89% | 19.44% | 17.02% |
Related:CNC Dividend History·CNC Revenue History·CNC Price History·CNC P/E History·CNC Financial Ratios·CNC Institutional Holders
CNC SEC Filings & Documents
Centene Corporation (CNC) SEC filings — annual & quarterly reports (10-K, 10-Q)
CNC Frequently Asked Questions
Centene Corporation (CNC) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Centene Corporation (CNC) grew revenue by 19.4% over the past year. This is strong growth.
Centene Corporation (CNC) reported a net loss of $6.44B for fiscal year 2025.
Dividend & Returns
Centene Corporation (CNC) has a return on equity (ROE) of -28.7%. Negative ROE indicates the company is unprofitable.
Industry Metrics
Centene Corporation (CNC) has a combined ratio of 103.9%. A ratio above 100% means claims and expenses exceed premiums.